Back
Madrigal Pharmaceuticals 10K Form
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $150K |
|---|---|
| Cash Flow: | $-140.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $39.50 |
| Price / Book: | 6.57 |
Profitability
| EPS (TTM): | -25.54000 |
|---|---|
| Net Income (TTM): | $-510.45M |
| Gross Margin: | $0 |
| Return on Equity: | -113.99% |
| Return on Assets: | -75.89% |
Madrigal Pharmaceuticals Earnings Forecast
Key Madrigal Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
- The Interest Expense is -3.40% of Operating Income.
- Per Share Earnings over the last 23 years have been positive in 8 years.
Madrigal Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 8.72 |
| Quick Ratio: | 8.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MDGL Technical Analysis vs Fundamental Analysis
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a Buy
The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.